| |
| |
|
| Insider
Information: |
Shabet Rose Sharon |
| Relationship: |
|
| City: |
Greenwich |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
18 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
415,583,308 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$3,624,554,674 |
|
|
| Total
Shares |
415,583,308 |
|
|
| Total
Value |
$3,624,554,674 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
8
|
|
Stock
price went up :
|
1
|
2
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 183.9%
|
 -174.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tekmira Pharmaceuticals Corp |
TKMR |
10% Owner |
|
0 |
2017-07-01 |
16,013,540 |
Premium* |
|
|
Sio Gene Therapies Inc |
SIOX |
10% Owner |
|
0 |
2019-03-18 |
105,952,381 |
Premium* |
|
|
Myovant Sciences Ltd. |
MYOV |
10% Owner |
|
0 |
2019-06-04 |
40,765,599 |
Premium* |
|
|
Urovant Sciences Ltd. |
UROV |
10% Owner |
2018-10-01 |
0 |
2019-06-19 |
22,860,013 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
10% Owner |
|
0 |
2020-12-14 |
29,993,708 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
|
2019-06-27 |
0 |
2023-07-18 |
25,120,991 |
Premium* |
|
|
Zentalis Pharmaceuticals, Llc |
ZNTL |
10% Owner |
|
0 |
2020-12-01 |
3,943,284 |
Premium* |
|
|
Inhibrx, Inc. |
INBX |
|
2020-08-24 |
0 |
2023-08-28 |
7,150,826 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
|
2020-12-15 |
0 |
2024-01-04 |
4,247,914 |
Premium* |
|
|
Rallybio Corp |
RLYB |
10% Owner |
2021-07-29 |
0 |
2021-07-29 |
4,194,777 |
Premium* |
|
|
Figs, Inc. |
FIGS |
10% Owner |
2021-09-02 |
0 |
2021-09-03 |
14,742,689 |
Premium* |
|
|
Procept Biorobotics Corp |
PRCT |
|
|
0 |
2021-09-14 |
308,142 |
Premium* |
|
|
Ginkgo Bioworks Holdings, Inc |
DNA |
|
|
0 |
2022-03-02 |
51,055,144 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2022-01-11 |
0 |
2022-01-11 |
2,300,000 |
Premium* |
|
|
Frazier Lifesciences Acquisition... |
FLAC |
|
2022-11-02 |
0 |
2022-11-02 |
1,211,582 |
Premium* |
|
|
Rayzebio, Inc. |
RYZB |
|
2023-09-19 |
0 |
2024-02-26 |
0 |
Premium* |
|
|
Api Group Corp |
APG |
|
2024-01-02 |
0 |
2024-03-05 |
27,071,548 |
Premium* |
|
|
Fluidigm Corp |
FLDM |
|
|
0 |
2024-03-18 |
58,651,170 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-03 |
4 |
AB |
$7.71 |
$41,815 |
I/I |
5,424 |
22,777,338 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-05-17 |
4 |
AB |
$7.36 |
$45,641 |
I/I |
6,200 |
0 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-05-29 |
4 |
AB |
$7.55 |
$51,983 |
I/I |
6,882 |
22,759,592 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-05 |
4 |
AB |
$8.02 |
$52,418 |
I/I |
6,540 |
22,791,378 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-07 |
4 |
AB |
$7.97 |
$52,959 |
I/I |
6,649 |
22,805,109 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-18 |
4 |
AB |
$8.21 |
$55,061 |
I/I |
6,706 |
22,855,056 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-17 |
4 |
AB |
$8.53 |
$55,825 |
I/I |
6,541 |
22,848,350 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-14 |
4 |
AB |
$7.91 |
$56,514 |
I/I |
7,144 |
22,841,809 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-06 |
4 |
AB |
$8.00 |
$56,621 |
I/I |
7,082 |
22,798,460 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-04 |
4 |
AB |
$7.59 |
$56,911 |
I/I |
7,500 |
22,784,838 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-05-30 |
4 |
AB |
$7.97 |
$58,090 |
I/I |
7,251 |
22,766,843 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-13 |
4 |
AB |
$7.95 |
$58,543 |
I/I |
7,367 |
22,834,665 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-11 |
4 |
AB |
$8.58 |
$61,694 |
I/I |
7,189 |
22,819,798 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-12 |
4 |
AB |
$8.30 |
$62,244 |
I/I |
7,500 |
22,827,298 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-10 |
4 |
AB |
$8.35 |
$62,594 |
I/I |
7,500 |
22,812,609 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-05-20 |
4 |
AB |
$7.98 |
$80,525 |
I/I |
10,000 |
0 |
0 |
- |
|
| INBX |
Inhibrx, Inc. |
10% Owner |
– – • |
2020-08-24 |
4 |
B |
$19.43 |
$897,001 |
I/I |
46,161 |
1,161,784 |
1.5 |
- |
|
| INBX |
Inhibrx, Inc. |
10% Owner |
– – • |
2020-08-25 |
4 |
B |
$19.23 |
$1,651,687 |
I/I |
85,304 |
1,247,088 |
1.5 |
- |
|
| FIGS |
Figs, Inc. |
10% Owner |
– – • |
2021-09-03 |
4 |
S |
$44.92 |
$1,905,192 |
I/I |
(42,413) |
14,742,689 |
0 |
% |
|
| INBX |
Inhibrx, Inc. |
10% Owner |
– – • |
2020-08-26 |
4 |
B |
$18.84 |
$3,409,866 |
I/I |
180,219 |
1,427,307 |
1.5 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
10% Owner |
– – • |
2019-07-01 |
4 |
B |
$20.00 |
$5,000,000 |
I/I |
250,000 |
1,675,000 |
1.5 |
- |
|
| FIGS |
Figs, Inc. |
10% Owner |
– – • |
2021-09-02 |
4 |
S |
$47.28 |
$7,450,713 |
I/I |
(157,587) |
14,785,102 |
0 |
% |
|
| FLAC |
Frazier Lifesciences Acqu... |
|
• • • |
2022-11-02 |
4 |
B |
$10.08 |
$8,538,385 |
I/I |
847,062 |
1,211,582 |
0.01 |
- |
|
| INBX |
Inhibrx, Inc. |
|
• • • |
2023-08-28 |
4 |
B |
$19.35 |
$9,899,982 |
I/I |
511,627 |
511,627 |
0.01 |
- |
|
| SIOX |
Sio Gene Therapies Inc |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$1.00 |
$10,000,000 |
I/I |
10,000,000 |
99,285,714 |
1.5 |
- |
|
74 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
